New York State Common Retirement Fund Eiger Bio Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.55 - $1.26 $15,794 - $36,184	-28,718 Reduced 98.8%	348 $0
Q4 2022 Jan 30, 2023	SELL	$1.02 - $7.48 $15 - $112	-15 Reduced 0.05%	29,066 $34,000
Q3 2022 Nov 08, 2022	BUY	$6.04 - $9.66 $84,131 - $134,554	13,929 Added 91.93%	29,081 $219,000
Q2 2022 Aug 04, 2022	SELL	$4.99 - $8.96 $254 - $456	-51 Reduced 0.34%	15,152 $95,000
Q1 2022 May 05, 2022	BUY	$3.84 - $9.74 $134 - $340	35 Added 0.23%	15,203 $126,000
Q4 2021 Feb 02, 2022	SELL	$5.12 - $8.19 $512 - $819	-100 Reduced 0.65%	15,168 $79,000
Q3 2021 Nov 02, 2021	SELL	$6.68 - $9.1 $77,447 - $105,505	-11,594 Reduced 43.16%	15,268 $102,000
Q2 2021 Aug 02, 2021	BUY	$7.82 - $9.23 $1,908 - $2,252	244 Added 0.92%	26,862 $229,000
Q1 2021 May 11, 2021	BUY	$8.44 - $12.66 $41,507 - $62,261	4,918 Added 22.66%	26,618 $236,000
Q4 2020 Feb 08, 2021	BUY	$7.98 - $12.29 $46,284 - $71,282	5,800 Added 36.48%	21,700 $267,000
Q1 2020 May 06, 2020	SELL	$4.91 - $14.7 $39,771 - $119,070	-8,100 Reduced 33.75%	15,900 $108,000
Q2 2019 Aug 09, 2019	BUY	$9.54 - $14.96 $228,959 - $359,040	24,000 New	24,000 $254,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.